Publications by authors named "T C Burton"

The design of interfaces between nanostructured electrodes and advanced electrolytes is critical for realizing advanced electrochemical double-layer capacitors (EDLCs) that combine high charge-storage capacity, high-rate capability, and enhanced safety. Toward this goal, this work presents a novel and sustainable approach for fabricating ionogel-based electrodes using a renewed slurry casting method, in which the solvent is replaced by the ionic liquid (IL), namely 1-ethyl-3-methylimidazolium bis(fluorosulfonyl)imide (EMIFSI). This method avoids time-consuming and costly electrolyte-filling steps by integrating the IL directly into the electrode during slurry preparation, while improving the rate capability of EDLCs based on non-flammable ILs.

View Article and Find Full Text PDF

Kidney damage and dysfunction is an emerging health issue worldwide resulting in high morbidity and mortality rates. Numerous renal diseases are recognized to be driven by the immune system. Despite this recognition, the development of targeted therapies has been challenging as knowledge of the underlying mechanism and complex interactions remains insufficient.

View Article and Find Full Text PDF

The European Union (EU) regulations mandate 10% of all food packaging to be reusable by 2030. United States (U.S.

View Article and Find Full Text PDF
Article Synopsis
  • Chronic airway inflammation can lead to conditions like COPD and asthma, causing issues such as goblet cell hyperplasia and obstructed airflow in chronic bronchitis.
  • Traditional animal testing methods are being replaced by in vitro three-dimensional cultures, but these often miss important characteristics of the human airway structure.
  • The Bronchus-on-a-Chip (BoC) system was developed to create a more accurate model of bronchial epithelium, successfully mimicking human responses to inflammation and improving the testing of chronic airway conditions.
View Article and Find Full Text PDF

Norovirus infections are a leading cause of gastroenteritis worldwide. Despite the substantial global health burden and economic impact, there are currently no approved antiviral therapeutics or vaccines. Additionally, much of our knowledge of norovirus comes from experiments using surrogate viruses, such as murine norovirus and feline calicivirus.

View Article and Find Full Text PDF